UK expands prostate cancer trial for black men
L'essentiel
- Tens of thousands more black men aged 45-74 in the UK will be invited for prostate cancer checks as part of an £18 million government-funded trial.
- The move aims to find better testing methods for the disease, which disproportionately affects black men.
Résumé généré par IA
Pourquoi c'est important
Tens of thousands more black men aged 45-74 are to be invited for prostate cancer checks as part of an ongoing trial in the UK. This move is welcomed by charities and campaigners as a "historic moment". The UK National Screening Committee recently recommended against regular PSA testing for most men due to harms outweighing benefits, except for those with specific genetic variants and family history.
Tens of thousands more black men aged 45-74 are to be invited for prostate cancer checks as part of an ongoing trial in the UK to find better ways of testing for the disease.
The move, announced by the government, has been welcomed by charities and campaigners as "a truly historic moment".
It comes as ministers have backed the UK National Screening Committee's recent recommendation that most men should not be offered regular testing for the disease.
The committee says the harms of using a blood test, called PSA, for screening outweigh the benefits in the majority of cases, except for "a few thousand" men who have a dangerous genetic variant and a family history of cancer.
Men can talk to their doctor about whether a PSA (prostate specific antigen) test might be helpful. People should not ignore prostate symptoms, such as difficulty urinating.
But while testing healthy men with no symptoms could save some lives, it would also lead to treatment that can leave men unable to control their bladder or have an erection.
Some prostate tumours do not needed treating immediately and may never be life-threatening, which is part of why widespread screening is not being recommended.
Prostate cancer is the most common cancer in men in the UK, with 64,000 men diagnosed and 12,000 dying each year.
One in eight men will get prostate cancer in their lifetime and for black men, that risk doubles to one in four.
The goverment says it will invest £18 million into the Transform trial so that more black men will be invited to take part in the research.
The trial is assessing whether extra tests alongside PSA, such as genetic checks and faster MRI scans, can improve screening accuracy.
All black men aged 45-74 who have not already had a recent PSA test will be offered the chance to participate.
The government says the trial will help build a more effective screening system for the disease for the future.
"This is a major step forward in how we tackle prostate cancer - focusing on those most at risk, improving the treatments available, and backing the research we need to close the evidence gaps and save lives," said Health Secretary James Murray.
À surveiller
Perspective IA — des possibilités, pas des certitudes
The Transform trial will provide data to support a more targeted prostate cancer screening program for black men.
Très probable · Moyen terme
The UK National Screening Committee's recommendations may be revised based on the trial's findings.
Probable · Moyen terme
Questions ouvertes
- What are the specific criteria for genetic variants and family history that warrant regular PSA testing?
- What are the long-term outcomes of the Transform trial regarding improved screening accuracy?
- How will the new screening system be implemented after the trial concludes?
- What are the specific side effects of treatments for over-diagnosed prostate cancers?
